{"name":"OncoTherapy Science, Inc.","slug":"oncotherapy-science-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"OTS167PO","genericName":"OTS167PO","slug":"ots167po","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"OTS167PO","genericName":"OTS167PO","slug":"ots167po","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5pZ2staERKXzY5UW9ueWNxU3FKd3JWLWlPODF4dG9vQlNjbzUzNUNFVEZtZWJHRmtGTjBwbjg4MDdGUjZIM1NxazAzR0lBMkxwdWxZSnNzNVRQbzVwUWNwWk9B?oc=5","date":"2026-04-07","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTFBSQXBOMW5PeVhuOHVaLUYzeUswZ3B1QXFwNEdWU28xc0ktSndQWnE3aFZKa2trTDBGMzFLVGdfdndnOGJHSWJXUldEeE5Rbk04Q0taY0hjY1pzaGFCS041Y3J3elBLa0RNeTgzNV9KSFlvNTRLUUcyeDdyVFJDVVpuTDNod3VqdHJDN0JQdUY?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"Triple Negative Breast Cancer Pipeline 2026: MOA, ROA, - openPR.com","headline":"Triple Negative Breast Cancer Pipeline 2026: MOA, ROA,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQcGhObzRGVFNvdEo4T2hPa2laVTV5WlhxTTVpTzJjWGhEZlhCRDRNTWF5Q0JPc2t2eHV4MUY3cWpmb1lROTJKRUJnbzZZTUhuemlBZVRaTnZBOWJxY1BPcjBpN1BZdUJNakd0UW04QnU2TlJ2NTZKVEViLWxQMi1MN2xTTQ?oc=5","date":"2025-09-26","type":"pipeline","source":"Fortune Business Insights","summary":"Bladder Cancer Vaccines Market Size, Share | Forecast [2034] - Fortune Business Insights","headline":"Bladder Cancer Vaccines Market Size, Share | Forecast [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"prnewswire.com","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - prnewswire.com","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-10-02","type":"regulatory","source":"GlobeNewswire","summary":"SERD Market is Predicted to Exhibit Remarkable Growth Owing - GlobeNewswire","headline":"SERD Market is Predicted to Exhibit Remarkable Growth Owing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOT013TWxzTkgwRVRJWXRVMWVSc3ZRZ3JjUTY0X3Qyc1dMdTNIaHV0RTFROEliYmVjRnVpZmx3ZXhKYjgzRUlFSTNSbnFURWdIbWR2UWN2a3BicHVWM2ZhRlpyRWFOQW5IT2pxbHdESkJ0U1VNeXU4Vk9QY2daYnhYMW5NaHAtc24xZ2c0SjJtdkNxOXR1cUFMMkZOWTE5bjZs?oc=5","date":"2023-06-11","type":"pipeline","source":"The Worldfolio","summary":"Developing new solutions in the fight against cancer - The Worldfolio","headline":"Developing new solutions in the fight against cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQam1KbmhxYWJFVVVvRmhBSDZXaURGZklkUkpRa1lmdVBfRmNwVmpvdTFDeWZscEZfcXhiUFNJU3JRNmplZVdVMThQT2Vadm1oaEFwVWg2cDY3TjNnUjBMTzFSRzNKSjQ1dkpIRUtXTzFuekxPOVYtWkhnYk9uVTBuUmVTWUZtSmFpRGFoekNDMU9sWXlxRnRQMVNZcC1iV3RadVRIM3NtNnhqT0RKYjhxTmJtX21PQVNIbTNNTk03WjQ?oc=5","date":"2023-01-05","type":"pipeline","source":"Pharmaceutical Technology","summary":"Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy - Pharmaceutical Technology","headline":"Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Zb0ZwTFhqZ2tWcWRfdTRjVmtIeTNTYUFGUGdJR0RIemV3S3Vlc3hYNl9rUmpUcUhIQVVWQ3Fna1pPNXNUaUU0eTFGZHRqOXNDcmZTaVY3RS1nSm5ud19n?oc=5","date":"2022-02-02","type":"pipeline","source":"Nature","summary":"Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides - Nature","headline":"Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding pep","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE80WFh2Q2tIRnU1Wk1jLTB3dUpYLUpHOGFlU0RtOExqd1hzUTlBZFZhbVBTaFNwQXk4SGlEMnR5UnJfN1B5UjBVNFVHZndUcE5oQm1MMFNkcw?oc=5","date":"2021-07-28","type":"pipeline","source":"EurekAlert!","summary":"Yusuke Nakamura, M.D., Ph.D., University of Chicago Medical Center (IMAGE) - EurekAlert!","headline":"Yusuke Nakamura, M.D., Ph.D., University of Chicago Medical Center (IMAGE) - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}